Anticholinergic Drugs Market Research, Global Analysis, Industry Demand and Forecast 2024
The Global Anticholinergic Drugs Market is expected to register a CAGR of 4.50% during the forecast period with a market value of USD 7,149.90 million till 2024. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.
The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.
Global Anticholinergic Drugs Market: Competitive Landscape
Some of the key players in the global Anticholinergic Drugs Market are
- Pfizer Inc. (US)
- Allergan Plc (US)
- Astellas Pharma Inc. (Japan)
- Johnson & Johnson Services Inc. (US)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sanofi (France)
- GlaxoSmithKline Plc (UK)
- Boehringer Ingelheim International GmbH (Germany)
Anticholinergic Drugs Market Segmentation
The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, semi-synthetic compounds. The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, muscle spasms, irritable bowel syndrome. On the basis of route of administration, the market is segmented into oral, parenteral, topical. On the basis of end user, the market is segmented into hospitals and pharmacies.
Anticholinergic Drugs Market Regional Analysis
The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.
Table Of Content
1. Market Introduction
1.1 Definition
1.2 Scope Of The Study
1.3 List Of Assumptions
1.4 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation
2.5 Forecast Model
3. Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Rising Geriatric Population
3.2.2 Increasing Prevalence Of Chronic Diseases
3.2.3 Increasing Investments And Funding In The Field Of Life Science Research
3.3 Restraints
3.3.1 Side-Effects Of Anticholinergic Drugs
3.3.2 Stringent Regulations
3.4 Opportunity
3.4.1 Entering Developing Economies
TOC Continued….!
About US:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com